Parallax Volatility Advisers
VIR icon

Parallax Volatility Advisers’s Vir Biotechnology VIR Stock Holding History

Parallax Volatility Advisers’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-45,000
Closed -$1.1M – 2644
2023
Q2 		$1.1M Hold
45,000
– – ﹤0.01% 1367
2023
Q1 		$1.05M Buy
+45,000
New +$1.15M ﹤0.01% 1484
2022
Q1 		– Sell
-400
Closed -$17K – 3242
2021
Q4 		$17K Buy
+400
New +$15.7K ﹤0.01% 1896
2021
Q3 		– Sell
-70,000
Closed -$3.31M – 2218
2021
Q2 		$3.31M Buy
+70,000
New +$3.18M ﹤0.01% 767
2021
Q1 		– Sell
-34,400
Closed -$921K – 2157
2020
Q4 		$921K Buy
+34,400
New +$1.12M ﹤0.01% 1461

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return